Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoclonal antibodies directed to the HER2 receptor

Monoclonal antibodies directed to the HER2 receptor

US Patent 5720954 · Granted Feb 24, 1998

Estimated economic value: $3,036,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies and enonomers2025
PH20 polypeptide variants with a modification at position 324 of the PH20 polype2025
PH20 polypeptide variants, formulations and uses thereof2025
PH20 polypeptide variants, formulations and uses thereof2025
PH20 polypeptide variants, formulations and uses thereof2024
PH20 polypeptide variants, formulations and uses thereof2024
PH20 polypeptide variants, formulations and uses thereof2024
PH20 polypeptide variants, formulations and uses thereof2024
PH20 polypeptide variants, formulations and uses thereof2024
PH20 polypeptide variants, formulations and uses thereof2024
PH20 polypeptide variants with a modification at position 309 of the PH20 polype2024
PH20 polypeptide variants, formulations and uses thereof2024